In the survey, the public is encouraged to note whether a standard should be kept, removed, modified or moved to a different section, according to a release.

GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) ...